Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

BioScience Health Innovations (BHIC) Gross Margin (2023 - 2025)

BioScience Health Innovations (BHIC) has disclosed Gross Margin for 3 consecutive years, with 36.36% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 1919.0% to 36.36% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 56.97% through Dec 2025, down 1398.0% year-over-year, with the annual reading at 56.97% for FY2025, 1398.0% down from the prior year.
  • Gross Margin for Q4 2025 was 36.36% at BioScience Health Innovations, down from 61.71% in the prior quarter.
  • The five-year high for Gross Margin was 86.33% in Q2 2023, with the low at 36.36% in Q4 2025.
  • Average Gross Margin over 3 years is 71.69%, with a median of 76.01% recorded in 2023.
  • Peak annual rise in Gross Margin hit -75bps in 2024, while the deepest fall reached -2234bps in 2024.
  • Over 3 years, Gross Margin stood at 77.89% in 2023, then fell by -29bps to 55.56% in 2024, then crashed by -35bps to 36.36% in 2025.
  • According to Business Quant data, Gross Margin over the past three periods came in at 36.36%, 61.71%, and 61.14% for Q4 2025, Q3 2025, and Q2 2025 respectively.